The reductions in lost workday equivalents (absenteeism and presenteeism) are assumed to continue as long as treatment is continued. The following chart shows the cumulative net benefit over a three year period of treating migraines in this workforce.
Three-year net present value of savings from triptan treatment:
| Currently on triptan: |
$16,497 |
|
Eligible for triptan: |
$111,696 |